Matthew D. La Fontaine

Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancer

Aniek J.G. Even, Bart Reymen, Matthew D. La Fontaine et al. · Radiotherapy and Oncology · 2017 · 32 citations · Full text

Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?

T. Konert, Sarah Everitt, Matthew D. La Fontaine et al. · PLoS ONE · 2020 · 25 citations · Full text

Oncologic Imaging, Pet-mri, Prognosis +23

Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer

Zeno A.R. Gouw, Matthew D. La Fontaine, Wouter V. Vogel et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 21 citations

Adaptive Radiotherapy, Neck Cancer, Radiation Therapy +11

Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT

Aniek J.G. Even, Bart Reymen, Matthew D. La Fontaine et al. · Acta Oncologica · 2017 · 20 citations · Full text

The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus–Positive Versus Human Papillomavirus–Negative Patients With Oropharyngeal Cancer

Zeno A.R. Gouw, Matthew D. La Fontaine, Simon van Kranen et al. · Clinical Nuclear Medicine · 2019 · 15 citations